Evidence map›Paper›PMID 37138907›Full record

ArticleFrontiers in veterinary science2023

Epidemiological characteristics and financial losses due to avian aspergillosis in households in the Almaty region, Republic of Kazakhstan.

Dinara Kalkayeva, Amangeldi Maulanov, Przemysław Sobiech, Mirosław Michalski, Gulnur Kuzembekova, Ainur Dzhangabulova, Nurzhan Nurkhojayev, Nurbek Aldayarov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Dinara KalkayevaDepartment of Biological Safety, Veterinary Faculty, Kazakh National Agrarian Research University, Almaty, Kazakhstan.
Amangeldi MaulanovDepartment of Biological Safety, Veterinary Faculty, Kazakh National Agrarian Research University, Almaty, Kazakhstan.
Przemysław SobiechDepartment of Parasitology and Invasive Diseases, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Mirosław MichalskiDepartment of Parasitology and Invasive Diseases, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Gulnur KuzembekovaDepartment of Biological Safety, Veterinary Faculty, Kazakh National Agrarian Research University, Almaty, Kazakhstan.
Ainur DzhangabulovaDepartment of Microbiology, Virology and Immunology, Veterinary Faculty, Kazakh National Agrarian Research University, Almaty, Kazakhstan.
Nurzhan NurkhojayevDepartment of Veterinary Medicine, Agrarian Faculty, Mukhtar Auezov South Kazakhstan University, Shymkent, Kazakhstan.
Nurbek AldayarovDepartment of Biology, Faculty of Sciences, Kyrgyz-Turkish Manas University, Bishkek, Kyrgyzstan.
Kazakh National Agrarian Research University · KZUniversity of Warmia and Mazury in Olsztyn · PLKyrgyz-Türkish Manas Üniversity · KGM.Auezov South Kazakhstan State University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillosis is a severe fungal disease that affects all species and ages of poultry and leads to significant economic losses within the poultry industry. The economic significance of aspergillosis is associated with direct losses due to poultry mortality, a decline in the production of meat and eggs, feed conversion, and poor growth of recovering poultry. Although a decrease in the production of poultry meat and eggs in Kazakhstan due to this fungal disease has been widely reported, studies on the consequent financial losses on affected farms (households) have not been carried out. This study aimed to estimate the financial losses and epidemiological parameters of avian aspergillosis among households affected by the disease in the Almaty region. To achieve the objectives of the research, a survey was conducted involving affected households from February 2018 to July 2019. The affected poultry were diagnosed based on clinical, macroscopical, and microscopical procedures, and once the infection was confirmed, household owners were interviewed. Data were collected from 183 household owners. The median incidence risk and fatality rates were 39 and 26% in chickens, 42 and 22% in turkeys, and 37 and 33% in geese, respectively, with young poultry having a higher incidence risk and fatality rate than adults. Approximately 92.4% of the household owners treated the affected poultry using natural folk methods and 7.6% of household owners used antifungal drugs and antibiotics, spending a median of US $35.20 (min US $0; max US $400) per household throughout the course of the infection. Egg production was reduced by a median of 58.3% when households were affected. The price of poultry fell by a median of 48.6% immediately after recovery due to weight loss. The median of the overall financial losses of households was US $198.50 (min US $11; max US $1,269). The majority of household owners (65%) did not replace their poultry, 9.8% of household owners replaced all their poultry, and the remaining 25.1% replaced only a proportion of the poultry lost at the time of the study. Newly acquired poultry were purchased from neighbors (10.9%), fellow villagers (50%), and state poultry farms (39.1%). This study demonstrates that aspergillosis has an immediate impact on subsistence household owners' livelihoods in the Almaty region of Kazakhstan.

Indexed as

aspergillosisepidemiological characteristicsfinancial losseshouseholdsKazakhstanpoultry

Identifiers

PMID37138907
PMCPMC10150056
OpenAlexW4366215466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.